Hilton Worldwide Holdings Inc. (HLT) stock
HLTNYSEHotels & MotelsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Oct 27, 2026Score 10/3092% above fair value
$356.92−0.01 (-0.00%)
Close on Oct 30, 2026Market cap $80.33BP/E 52.3Yield 0.17%
Earnings
Hilton Worldwide's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Next report
Feb 10, 2027
Q4 FY2026 · estimated, before the open
Revenue, Q3 FY2026
$3.33B
+6.6% on a year earlier
diluted EPS, adjusted for special items, Q3 FY2026
$2.45
$2.11 a year earlier
Latest guidance
Lowered
Oct 27, 2026 · 14 items
Quarterly results
Revenue and earnings per share from each of Hilton Worldwide's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Adj. EPS | Source |
|---|---|---|---|---|---|---|
| Q4 FY2026ended Dec 31, 2026 | Feb 10, 2027Expected | – | – | – | – | – |
| Q3 FY2026ended Sep 30, 2026 | Oct 27, 2026before the open | $3.33B | +6.6% | $2.37 | $2.45 | Release |
| Q2 FY2026ended Jun 30, 2026 | Jul 28, 2026before the open | $3.34B | +6.5% | $2.10 | $2.29 | Release |
| Q1 FY2026ended Mar 31, 2026 | Apr 28, 2026before the open | $2.94B | +9.0% | $1.66 | $2.01 | Release |
| Q4 FY2025ended Dec 31, 2025 | Feb 11, 2026before the open | $3.09B | +10.9% | $1.27 | $2.08 | Release |
| Q3 FY2025ended Sep 30, 2025 | Oct 22, 2025before the open | $3.12B | +8.8% | $1.78 | $2.11 | Release |
| Q2 FY2025ended Jun 30, 2025 | Jul 23, 2025before the open | $3.14B | +6.3% | $1.84 | $2.20 | Release |
| Q1 FY2025ended Mar 31, 2025 | Apr 29, 2025before the open | $2.70B | +4.7% | $1.23 | $1.72 | Release |
| Q4 FY2024ended Dec 31, 2024 | Feb 6, 2025before the open | $2.78B | +6.7% | $2.06 | $1.76 | Release |
| Q3 FY2024ended Sep 30, 2024 | Oct 23, 2024before the open | $2.87B | +7.3% | $1.38 | $1.92 | Release |
| Q2 FY2024ended Jun 30, 2024 | Aug 7, 2024before the open | $2.95B | +10.9% | $1.67 | $1.91 | Release |
| Q1 FY2024ended Mar 31, 2024 | Apr 24, 2024before the open | $2.57B | +12.2% | $1.04 | $1.53 | Release |
| Q4 FY2023ended Dec 31, 2023 | Feb 7, 2024before the open | $2.61B | +6.8% | $0.57 | $1.68 | Release |
| Q3 FY2023ended Sep 30, 2023 | Oct 25, 2023before the open | $2.67B | +12.9% | $1.44 | $1.67 | Release |
| Q2 FY2023ended Jun 30, 2023 | Jul 26, 2023before the open | $2.66B | +18.8% | $1.55 | $1.63 | Release |
| Q1 FY2023ended Mar 31, 2023 | Apr 26, 2023before the open | $2.29B | +33.2% | $0.77 | $1.24 | Release |
| Q4 FY2022ended Dec 31, 2022 | Feb 9, 2023before the open | $2.44B | +33.1% | $1.21 | $1.59 | Release |
| Q3 FY2022ended Sep 30, 2022 | Oct 26, 2022before the open | $2.37B | +35.4% | $1.26 | $1.31 | Release |
| Q2 FY2022ended Jun 30, 2022 | Jul 27, 2022before the open | $2.24B | – | $1.32 | $1.29 | Release |
| Q1 FY2022ended Mar 31, 2022 | May 3, 2022before the open | $1.72B | – | $0.75 | $0.71 | Release |
| Q4 FY2021ended Dec 31, 2021 | Feb 16, 2022before the open | $1.84B | – | $0.52 | $0.72 | Release |
| Q3 FY2021ended Sep 30, 2021 | Oct 27, 2021before the open | $1.75B | – | $0.86 | $0.78 | Release |
| Q2 FY2021ended Jun 30, 2021 | Jul 29, 2021before the open | – | – | – | – | Filing |
| Q1 FY2021ended Mar 31, 2021 | May 5, 2021before the open | – | – | – | – | Filing |
| Q4 FY2020ended Dec 31, 2020 | Jan 19, 2021before the open | – | – | – | – | Filing |
| Q3 FY2020ended Sep 30, 2020 | Nov 4, 2020before the open | – | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
Hilton Worldwide's latest outlook for periods it has not reported yet, compared with what it said before
| Metric | Period | Guidance | Before | Change | Given |
|---|---|---|---|---|---|
| System-wide comparable RevPAR, on a currency neutral basisnon-GAAP | Q4 FY2026 | +3% – +3.5% | – | New | Oct 27, 2026 |
| Adjusted EBITDAnon-GAAP | Q4 FY2026 | $1.05B – $1.07B | – | New | Oct 27, 2026 |
| Diluted EPSGAAP | Q4 FY2026 | $2.25 – $2.31 | – | New | Oct 27, 2026 |
| Diluted EPS, adjusted for special itemsnon-GAAP | Q4 FY2026 | $2.32 – $2.38 | – | New | Oct 27, 2026 |
| Net incomeGAAP | Q4 FY2026 | $508.00M – $522.00M | – | New | Oct 27, 2026 |
| System-wide comparable RevPAR, on a currency neutral basisnon-GAAP | FY2026 | +4% – +4.5% | – | New | Oct 27, 2026 |
| System-wide comparable RevPAR, on a currency neutral basis | FY2026 | +3% – +3.5% | +2% – +3% | Raised | Jul 28, 2026 |
| Adjusted EBITDAnon-GAAP | FY2026 | $4.06B – $4.08B | – | New | Oct 27, 2026 |
| Adjusted EBITDAnon-GAAP | FY2026 | $4.04B – $4.08B | $4.02B – $4.06B | Raised | Jul 28, 2026 |
| Diluted EPSGAAP | FY2026 | $8.38 – $8.44 | – | New | Oct 27, 2026 |
| Diluted EPSGAAP | FY2026 | $8.22 – $8.35 | $8.28 – $8.40 | Lowered | Jul 28, 2026 |
| Diluted EPS, adjusted for special itemsnon-GAAP | FY2026 | $9.07 – $9.13 | – | New | Oct 27, 2026 |
| Diluted EPS, adjusted for special itemsnon-GAAP | FY2026 | $8.89 – $9.01 | $8.79 – $8.91 | Raised | Jul 28, 2026 |
| Contract acquisition costs and capital expenditures, excluding amounts reimbursed by third partiesnon-GAAP | FY2026 | $350.00M – $375.00M | – | New | Oct 27, 2026 |
| Contract acquisition costs and capital expenditures, excluding amounts reimbursed by third parties | FY2026 | $300.00M | $300.00M | Reaffirmed | Jul 28, 2026 |
| Capital return | FY2026 | $3.50B | – | New | Oct 27, 2026 |
| Capital return | FY2026 | $3.50B | $3.50B | Raised | Jul 28, 2026 |
| General and administrative expenses | FY2026 | $400.00M | – | Lowered | Oct 27, 2026 |
| General and administrative expenses | FY2026 | $400.00M | $400.00M | Lowered | Jul 28, 2026 |
| Net incomeGAAP | FY2026 | $1.91B – $1.92B | – | New | Oct 27, 2026 |
| Net incomeGAAP | FY2026 | $1.88B – $1.91B | $1.91B – $1.94B | Lowered | Jul 28, 2026 |
| Net unit growth | FY2026 | +6% – +7% | – | New | Oct 27, 2026 |
| Net unit growth | FY2026 | +6% – +7% | +6% – +7% | Reaffirmed | Jul 28, 2026 |
Guidance vs results
The last range Hilton Worldwide gave before each report, against the figure it then reported. Full years add up the four quarters.
| Period | Metric | Guidance | Actual | Result |
|---|---|---|---|---|
| Q3 FY2026 | Diluted EPS, adjusted for special items | $2.28 – $2.34 | $2.45 | Above range |
| Q3 FY2026 | EPS (GAAP) | $2.20 – $2.26 | $2.37 | Above range |
| Q2 FY2026 | Diluted EPS, adjusted for special items | $2.18 – $2.24 | $2.29 | Above range |
| Q2 FY2026 | EPS (GAAP) | $2.13 – $2.19 | $2.10 | Below range |
| Q1 FY2026 | Diluted EPS, adjusted for special items | $1.91 – $1.97 | $2.01 | Above range |
| Q1 FY2026 | EPS (GAAP) | $1.87 – $1.93 | $1.66 | Below range |
| FY2025 | Diluted EPS, adjusted for special items | $7.97 – $8.06 | $8.11Σ4Q | Above range |
| FY2025 | EPS (GAAP) | $6.71 – $6.80 | $6.12Σ4Q | Below range |
| Q4 FY2025 | Diluted EPS, adjusted for special items | $1.94 – $2.03 | $2.08 | Above range |
| Q4 FY2025 | EPS (GAAP) | $1.87 – $1.96 | $1.27 | Below range |
| Q3 FY2025 | Diluted EPS, adjusted for special items | $1.98 – $2.04 | $2.11 | Above range |
| Q3 FY2025 | EPS (GAAP) | $1.89 – $1.95 | $1.78 | Below range |
| Q2 FY2025 | Diluted EPS, adjusted for special items | $1.97 – $2.02 | $2.20 | Above range |
| Q2 FY2025 | EPS (GAAP) | $1.88 – $1.94 | $1.84 | Below range |
| Q1 FY2025 | Diluted EPS, adjusted for special items | $1.57 – $1.63 | $1.72 | Above range |
| Q1 FY2025 | EPS (GAAP) | $1.52 – $1.58 | $1.23 | Below range |
| Q4 FY2024 | Diluted EPS, adjusted for special items | $1.57 – $1.67 | $1.76 | Above range |
| Q4 FY2024 | EPS (GAAP) | $1.49 – $1.59 | $2.06 | Above range |
| Q3 FY2024 | Diluted EPS, adjusted for special items | $1.80 – $1.85 | $1.92 | Above range |
| Q3 FY2024 | EPS (GAAP) | $1.74 – $1.79 | $1.38 | Below range |
| Q2 FY2024 | Diluted EPS, adjusted for special items | $1.80 – $1.86 | $1.91 | Above range |
| Q2 FY2024 | EPS (GAAP) | $1.74 – $1.80 | $1.67 | Below range |
| Q1 FY2024 | Diluted EPS, adjusted for special items | $1.36 – $1.44 | $1.53 | Above range |
| Q1 FY2024 | EPS (GAAP) | $1.32 – $1.40 | $1.04 | Below range |
| Q4 FY2023 | Diluted EPS, adjusted for special items | $1.51 – $1.56 | $1.68 | Above range |
| Q4 FY2023 | EPS (GAAP) | $1.43 – $1.48 | $0.57 | Below range |
| Q3 FY2023 | Diluted EPS, adjusted for special items | $1.60 – $1.65 | $1.67 | Above range |
| Q3 FY2023 | EPS (GAAP) | $1.49 – $1.54 | $1.44 | Below range |
| Q2 FY2023 | Diluted EPS, adjusted for special items | $1.54 – $1.59 | $1.63 | Above range |
| Q2 FY2023 | EPS (GAAP) | $1.45 – $1.50 | $1.55 | Above range |
| Q1 FY2023 | Diluted EPS, adjusted for special items | $1.08 – $1.14 | $1.24 | Above range |
| Q1 FY2023 | EPS (GAAP) | $1.00 – $1.06 | $0.77 | Below range |
| Q4 FY2022 | Diluted EPS, adjusted for special items | $1.15 – $1.23 | $1.59 | Above range |
| Q4 FY2022 | EPS (GAAP) | $1.08 – $1.15 | $1.21 | Above range |
| Q3 FY2022 | Diluted EPS, adjusted for special items | $1.16 – $1.24 | $1.31 | Above range |
| Q3 FY2022 | EPS (GAAP) | $1.09 – $1.16 | $1.26 | Above range |
| Q2 FY2022 | Diluted EPS, adjusted for special items | $0.98 – $1.03 | $1.29 | Above range |
| Q2 FY2022 | EPS (GAAP) | $0.89 – $0.94 | $1.32 | Above range |
Guidance history
Every forecast Hilton Worldwide put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Oct 27, 2026 | Contract acquisition costs and capital expenditures, excluding amounts reimbursed by third parties | FY2026 | $350.00M – $375.00M | New |
| Oct 27, 2026 | System-wide comparable RevPAR, on a currency neutral basis | Q4 FY2026 | +3% – +3.5% | New |
| Oct 27, 2026 | System-wide comparable RevPAR, on a currency neutral basis | FY2026 | +4% – +4.5% | New |
| Oct 27, 2026 | Adjusted EBITDA | Q4 FY2026 | $1.05B – $1.07B | New |
| Oct 27, 2026 | Adjusted EBITDA | FY2026 | $4.06B – $4.08B | New |
| Oct 27, 2026 | Diluted EPS, adjusted for special items | FY2026 | $9.07 – $9.13 | New |
| Oct 27, 2026 | Diluted EPS, adjusted for special items | Q4 FY2026 | $2.32 – $2.38 | New |
| Oct 27, 2026 | Diluted EPS | Q4 FY2026 | $2.25 – $2.31 | New |
| Oct 27, 2026 | Diluted EPS | FY2026 | $8.38 – $8.44 | New |
| Oct 27, 2026 | Capital return | FY2026 | $3.50B | New |
| Oct 27, 2026 | Net income | Q4 FY2026 | $508.00M – $522.00M | New |
| Oct 27, 2026 | Net unit growth | FY2026 | +6% – +7% | New |
| Oct 27, 2026 | General and administrative expenses | FY2026 | $400.00M | Lowered |
| Oct 27, 2026 | Net income | FY2026 | $1.91B – $1.92B | New |
| Jul 28, 2026 | Contract acquisition costs and capital expenditures, excluding amounts reimbursed by third parties | FY2026 | $300.00M | Reaffirmed |
| Jul 28, 2026 | System-wide comparable RevPAR, on a currency neutral basis | FY2026 | +3% – +3.5% | Raised |
| Jul 28, 2026 | System-wide comparable RevPAR, on a currency neutral basis | Q3 FY2026 | +4% | New |
| Jul 28, 2026 | Adjusted EBITDA | FY2026 | $4.04B – $4.08B | Raised |
| Jul 28, 2026 | Adjusted EBITDA | Q3 FY2026 | $1.04B – $1.06B | New |
| Jul 28, 2026 | Diluted EPS, adjusted for special items | FY2026 | $8.89 – $9.01 | Raised |
| Jul 28, 2026 | Diluted EPS, adjusted for special items | Q3 FY2026 | $2.28 – $2.34 | New |
| Jul 28, 2026 | Diluted EPS | FY2026 | $8.22 – $8.35 | Lowered |
| Jul 28, 2026 | Diluted EPS | Q3 FY2026 | $2.20 – $2.26 | New |
| Jul 28, 2026 | Net unit growth | FY2026 | +6% – +7% | Reaffirmed |
| Jul 28, 2026 | Capital return | FY2026 | $3.50B | Raised |
| Jul 28, 2026 | General and administrative expenses | FY2026 | $400.00M | Lowered |
| Jul 28, 2026 | Net income | FY2026 | $1.88B – $1.91B | Lowered |
| Jul 28, 2026 | Net income | Q3 FY2026 | $502.00M – $516.00M | New |
| Apr 28, 2026 | Contract acquisition costs and capital expenditures, excluding amounts reimbursed by third parties | FY2026 | $300.00M | Reaffirmed |
| Apr 28, 2026 | System-wide comparable RevPAR | FY2026 | +2% – +3% | Raised |
| Apr 28, 2026 | System-wide comparable RevPAR | Q2 FY2026 | +2% – +3% | New |
| Apr 28, 2026 | Adjusted EBITDA | FY2026 | $4.02B – $4.06B | Raised |
| Apr 28, 2026 | Adjusted EBITDA | Q2 FY2026 | $1.02B – $1.04B | New |
| Apr 28, 2026 | Diluted EPS, adjusted for special items | FY2026 | $8.79 – $8.91 | Raised |
| Apr 28, 2026 | Diluted EPS, adjusted for special items | Q2 FY2026 | $2.18 – $2.24 | New |
| Apr 28, 2026 | Diluted EPS | FY2026 | $8.28 – $8.40 | Lowered |
| Apr 28, 2026 | Diluted EPS | Q2 FY2026 | $2.13 – $2.19 | New |
| Apr 28, 2026 | Net unit growth | FY2026 | +6% – +7% | Reaffirmed |
| Apr 28, 2026 | Capital return | FY2026 | $3.50B | Raised |
| Apr 28, 2026 | General and administrative expenses | FY2026 | $400.00M | Lowered |
| Apr 28, 2026 | Net income | FY2026 | $1.91B – $1.94B | Lowered |
| Apr 28, 2026 | Net income | Q2 FY2026 | $491.00M – $505.00M | New |
| Feb 11, 2026 | Contract acquisition costs and capital expenditures, excluding amounts reimbursed by third parties | FY2026 | $300.00M | New |
| Feb 11, 2026 | System-wide comparable RevPAR, on a currency neutral basis | FY2026 | +1% – +2% | New |
| Feb 11, 2026 | System-wide comparable RevPAR, on a currency neutral basis | Q1 FY2026 | +1% – +2% | New |
| Feb 11, 2026 | Adjusted EBITDA | FY2026 | $4.00B – $4.04B | New |
| Feb 11, 2026 | Adjusted EBITDA | Q1 FY2026 | $875.00M – $895.00M | New |
| Feb 11, 2026 | Diluted EPS, adjusted for special items | FY2026 | $8.65 – $8.77 | New |
| Feb 11, 2026 | Diluted EPS, adjusted for special items | Q1 FY2026 | $1.91 – $1.97 | New |
| Feb 11, 2026 | Diluted EPS | FY2026 | $8.49 – $8.61 | New |
| Feb 11, 2026 | Diluted EPS | Q1 FY2026 | $1.87 – $1.93 | New |
| Feb 11, 2026 | Net unit growth | FY2026 | +6% – +7% | New |
| Feb 11, 2026 | Capital return | FY2026 | $3.50B | New |
| Feb 11, 2026 | General and administrative expenses | FY2026 | $400.00M | Lowered |
| Feb 11, 2026 | Net income | FY2026 | $1.98B – $2.01B | New |
| Feb 11, 2026 | Net income | Q1 FY2026 | $436.00M – $450.00M | New |
| Oct 22, 2025 | Contract acquisition costs and capital expenditures, excluding amounts reimbursed by third parties | FY2025 | $250.00M – $300.00M | Reaffirmed |
| Oct 22, 2025 | System-wide comparable RevPAR, on a currency neutral basis | Q4 FY2025 | +1% | New |
| Oct 22, 2025 | Adjusted EBITDA | FY2025 | $3.69B – $3.72B | Raised |
| Oct 22, 2025 | Adjusted EBITDA | Q4 FY2025 | $906.00M – $936.00M | New |
| Oct 22, 2025 | Diluted EPS, adjusted for special items | FY2025 | $7.97 – $8.06 | Raised |
| Oct 22, 2025 | Diluted EPS, adjusted for special items | Q4 FY2025 | $1.94 – $2.03 | New |
| Oct 22, 2025 | Diluted EPS | FY2025 | $6.71 – $6.80 | Lowered |
| Oct 22, 2025 | Diluted EPS | Q4 FY2025 | $1.87 – $1.96 | New |
| Oct 22, 2025 | Net unit growth | FY2025 | +6.5% – +7% | Raised |
| Oct 22, 2025 | Capital return | FY2025 | $3.30B | Raised |
| Oct 22, 2025 | General and administrative expenses | FY2025 | $410.00M – $420.00M | Lowered |
| Oct 22, 2025 | Net income | FY2025 | $1.60B – $1.63B | Lowered |
| Oct 22, 2025 | Net income | Q4 FY2025 | $441.00M – $462.00M | New |
| Jul 23, 2025 | Contract acquisition costs and capital expenditures, excluding amounts reimbursed by third parties | FY2025 | $250.00M – $300.00M | New |
| Jul 23, 2025 | Adjusted EBITDA | FY2025 | $3.65B – $3.71B | New |
| Jul 23, 2025 | Adjusted EBITDA | Q3 FY2025 | $935.00M – $955.00M | New |
| Jul 23, 2025 | Diluted EPS, adjusted for special items | FY2025 | $7.83 – $8.00 | New |
| Jul 23, 2025 | Diluted EPS, adjusted for special items | Q3 FY2025 | $1.98 – $2.04 | New |
| Jul 23, 2025 | Diluted EPS | FY2025 | $6.82 – $6.99 | New |
| Jul 23, 2025 | Diluted EPS | Q3 FY2025 | $1.89 – $1.95 | New |
| Jul 23, 2025 | Net unit growth | FY2025 | +6% – +7% | New |
| Jul 23, 2025 | Capital return | FY2025 | $3.30B | New |
| Jul 23, 2025 | General and administrative expenses | FY2025 | $420.00M – $430.00M | Lowered |
| Jul 23, 2025 | Net income | FY2025 | $1.64B – $1.68B | New |
| Jul 23, 2025 | Net income | Q3 FY2025 | $453.00M – $467.00M | New |
| Apr 29, 2025 | Contract acquisition costs and capital expenditures, excluding amounts reimbursed by third parties | FY2025 | $250.00M – $300.00M | Reaffirmed |
| Apr 29, 2025 | Adjusted EBITDA | Q2 FY2025 | $940.00M – $960.00M | New |
| Apr 29, 2025 | Adjusted EBITDA | FY2025 | $3.65B – $3.71B | Lowered |
| Apr 29, 2025 | Diluted EPS, adjusted for special items | Q2 FY2025 | $1.97 – $2.02 | New |
| Apr 29, 2025 | Diluted EPS, adjusted for special items | FY2025 | $7.76 – $7.94 | Raised |
| Apr 29, 2025 | Diluted EPS | Q2 FY2025 | $1.88 – $1.94 | New |
| Apr 29, 2025 | Diluted EPS | FY2025 | $7.04 – $7.22 | Lowered |
| Apr 29, 2025 | Net income | Q2 FY2025 | $455.00M – $469.00M | New |
| Apr 29, 2025 | Net unit growth | FY2025 | +6% – +7% | Reaffirmed |
| Apr 29, 2025 | Capital return | FY2025 | $3.30B | Raised |
| Apr 29, 2025 | General and administrative expenses | FY2025 | $420.00M – $430.00M | Lowered |
| Apr 29, 2025 | Net income | FY2025 | $1.71B – $1.75B | Lowered |
| Feb 6, 2025 | Contract acquisition costs and capital expenditures, excluding amounts reimbursed by third parties | FY2025 | $250.00M – $300.00M | New |
| Feb 6, 2025 | System-wide comparable RevPAR, on a currency neutral basis | Q1 FY2025 | +2.5% – +3.5% | New |
| Feb 6, 2025 | System-wide comparable RevPAR, on a currency neutral basis | FY2025 | +2% – +3% | New |
| Feb 6, 2025 | Adjusted EBITDA | Q1 FY2025 | $770.00M – $790.00M | New |
| Feb 6, 2025 | Adjusted EBITDA | FY2025 | $3.70B – $3.74B | New |
| Feb 6, 2025 | Diluted EPS, adjusted for special items | Q1 FY2025 | $1.57 – $1.63 | New |
| Feb 6, 2025 | Diluted EPS, adjusted for special items | FY2025 | $7.71 – $7.82 | New |
| Feb 6, 2025 | Diluted EPS | Q1 FY2025 | $1.52 – $1.58 | New |
| Feb 6, 2025 | Diluted EPS | FY2025 | $7.45 – $7.56 | New |
| Feb 6, 2025 | Net income | Q1 FY2025 | $373.00M – $388.00M | New |
| Feb 6, 2025 | Net unit growth | FY2025 | +6% – +7% | Reaffirmed |
| Feb 6, 2025 | Capital return | FY2025 | $3.30B | New |
| Feb 6, 2025 | General and administrative expenses | FY2025 | $420.00M – $430.00M | Lowered |
| Feb 6, 2025 | Net income | FY2025 | $1.83B – $1.86B | New |
| Oct 23, 2024 | Contract acquisition costs and capital expenditures, excluding amounts reimbursed by third parties | FY2024 | $200.00M – $250.00M | Lowered |
| Oct 23, 2024 | System-wide comparable RevPAR, on a currency neutral basis | Q4 FY2024 | +1% – +2% | New |
| Oct 23, 2024 | System-wide comparable RevPAR, on a currency neutral basis | FY2024 | +2% – +2.5% | Lowered |
| Oct 23, 2024 | Adjusted EBITDA | Q4 FY2024 | $804.00M – $834.00M | New |
| Oct 23, 2024 | Adjusted EBITDA | FY2024 | $3.38B – $3.41B | Reaffirmed |
| Oct 23, 2024 | Diluted EPS, adjusted for special items | Q4 FY2024 | $1.57 – $1.67 | New |
| Oct 23, 2024 | Diluted EPS, adjusted for special items | FY2024 | $6.93 – $7.03 | Reaffirmed |
| Oct 23, 2024 | Diluted EPS | Q4 FY2024 | $1.49 – $1.59 | New |
| Oct 23, 2024 | Diluted EPS | FY2024 | $5.58 – $5.68 | Lowered |
| Oct 23, 2024 | Net income | Q4 FY2024 | $371.00M – $395.00M | New |
| Oct 23, 2024 | Net unit growth | FY2024 | +7% – +7.5% | Reaffirmed |
| Oct 23, 2024 | Capital return | FY2024 | $3.00B | Raised |
| Oct 23, 2024 | General and administrative expenses | FY2024 | $415.00M – $430.00M | Lowered |
| Oct 23, 2024 | Net income | FY2024 | $1.41B – $1.43B | Lowered |
| Oct 23, 2024 | Net unit growth | FY2025 | +6% – +7% | New |
| Aug 7, 2024 | Contract acquisition costs and capital expenditures, excluding amounts reimbursed by third parties | FY2024 | $250.00M – $300.00M | Reaffirmed |
| Aug 7, 2024 | System-wide comparable RevPAR, on a currency neutral basis | Q3 FY2024 | +2% – +3% | New |
| Aug 7, 2024 | System-wide comparable RevPAR, on a currency neutral basis | FY2024 | +2% – +3% | Lowered |
| Aug 7, 2024 | Adjusted EBITDA | Q3 FY2024 | $875.00M – $890.00M | New |
| Aug 7, 2024 | Adjusted EBITDA | FY2024 | $3.38B – $3.41B | Lowered |
| Aug 7, 2024 | Diluted EPS, adjusted for special items | Q3 FY2024 | $1.80 – $1.85 | New |
| Aug 7, 2024 | Diluted EPS, adjusted for special items | FY2024 | $6.93 – $7.03 | Raised |
| Aug 7, 2024 | Diluted EPS | Q3 FY2024 | $1.74 – $1.79 | New |
| Aug 7, 2024 | Diluted EPS | FY2024 | $6.06 – $6.15 | Lowered |
| Aug 7, 2024 | Net income | Q3 FY2024 | $435.00M – $448.00M | New |
| Aug 7, 2024 | Net unit growth | FY2024 | +7% – +7.5% | Raised |
| Aug 7, 2024 | Capital return | FY2024 | $3.00B | Raised |
| Aug 7, 2024 | General and administrative expenses | FY2024 | $415.00M – $430.00M | Lowered |
| Aug 7, 2024 | Net income | FY2024 | $1.53B – $1.56B | Lowered |
| Apr 24, 2024 | Contract acquisition costs and capital expenditures, excluding amounts reimbursed by third parties | FY2024 | $250.00M – $300.00M | Reaffirmed |
| Apr 24, 2024 | System-wide comparable RevPAR | Q2 FY2024 | +2% – +4% | New |
| Apr 24, 2024 | System-wide comparable RevPAR | FY2024 | +2% – +4% | New |
| Apr 24, 2024 | Adjusted EBITDA | Q2 FY2024 | $890.00M – $910.00M | New |
| Apr 24, 2024 | Adjusted EBITDA | FY2024 | $3.38B – $3.43B | Raised |
| Apr 24, 2024 | Diluted EPS, adjusted for special items | Q2 FY2024 | $1.80 – $1.86 | New |
| Apr 24, 2024 | Diluted EPS, adjusted for special items | FY2024 | $6.89 – $7.03 | Raised |
| Apr 24, 2024 | Diluted EPS | Q2 FY2024 | $1.74 – $1.80 | New |
| Apr 24, 2024 | Diluted EPS | FY2024 | $6.21 – $6.35 | Lowered |
| Apr 24, 2024 | Net income | Q2 FY2024 | $443.00M – $457.00M | New |
| Apr 24, 2024 | Net unit growth, excluding the effect of the planned acquisition of the Graduate Hotels brand | FY2024 | +6% – +6.5% | Raised |
| Apr 24, 2024 | Capital return | FY2024 | $3.00B | Raised |
| Apr 24, 2024 | General and administrative expenses | FY2024 | $415.00M – $430.00M | Lowered |
| Apr 24, 2024 | Net income | FY2024 | $1.59B – $1.62B | Lowered |
| Feb 7, 2024 | Contract acquisition costs and capital expenditures, excluding amounts reimbursed by third parties | FY2024 | $250.00M – $300.00M | New |
| Feb 7, 2024 | System-wide comparable RevPAR | Q1 FY2024 | +2% – +4% | New |
| Feb 7, 2024 | System-wide comparable RevPAR | FY2024 | +2% – +4% | New |
| Feb 7, 2024 | Adjusted EBITDA | Q1 FY2024 | $690.00M – $710.00M | New |
| Feb 7, 2024 | Adjusted EBITDA | FY2024 | $3.33B – $3.38B | New |
| Feb 7, 2024 | Diluted EPS, adjusted for special items | Q1 FY2024 | $1.36 – $1.44 | New |
| Feb 7, 2024 | Diluted EPS, adjusted for special items | FY2024 | $6.80 – $6.94 | New |
| Feb 7, 2024 | Diluted EPS | Q1 FY2024 | $1.32 – $1.40 | New |
| Feb 7, 2024 | Diluted EPS | FY2024 | $6.57 – $6.71 | New |
| Feb 7, 2024 | Net income | Q1 FY2024 | $340.00M – $359.00M | New |
| Feb 7, 2024 | Net unit growth | FY2024 | +5.5% – +6% | New |
| Feb 7, 2024 | Capital return | FY2024 | $3.00B | New |
| Feb 7, 2024 | General and administrative expenses | FY2024 | $415.00M – $430.00M | Lowered |
| Feb 7, 2024 | Net income | FY2024 | $1.69B – $1.73B | New |
| Oct 25, 2023 | Contract acquisition costs and capital expenditures, excluding amounts reimbursed by third parties | FY2023 | $350.00M | Raised |
| Oct 25, 2023 | System-wide comparable RevPAR, on a currency neutral basis | Q4 FY2023 | +4.5% – +5.5% | New |
| Oct 25, 2023 | System-wide comparable RevPAR, on a currency neutral basis | FY2023 | +12% – +12.5% | Raised |
| Oct 25, 2023 | Adjusted EBITDA | Q4 FY2023 | $739.00M – $759.00M | New |
| Oct 25, 2023 | Adjusted EBITDA | FY2023 | $3.03B – $3.05B | Raised |
| Oct 25, 2023 | Diluted EPS, adjusted for special items | Q4 FY2023 | $1.51 – $1.56 | New |
| Oct 25, 2023 | Diluted EPS, adjusted for special items | FY2023 | $6.04 – $6.09 | Raised |
| Oct 25, 2023 | Diluted EPS | Q4 FY2023 | $1.43 – $1.48 | New |
| Oct 25, 2023 | Diluted EPS | FY2023 | $5.17 – $5.22 | Lowered |
| Oct 25, 2023 | Net income | Q4 FY2023 | $374.00M – $388.00M | New |
| Oct 25, 2023 | Net unit growth | FY2023 | +5% | Reaffirmed |
| Oct 25, 2023 | Capital return | FY2023 | $2.40B – $2.60B | Raised |
| Oct 25, 2023 | Net income | FY2023 | $1.38B – $1.39B | Lowered |
| Oct 25, 2023 | General and administrative expenses | FY2023 | $390.00M – $410.00M | Lowered |
| Jul 26, 2023 | Contract acquisition costs and capital expenditures, excluding amounts reimbursed by third parties | FY2023 | $300.00M | Reaffirmed |
| Jul 26, 2023 | System-wide comparable RevPAR | Q3 FY2023 | +4% – +6% | New |
| Jul 26, 2023 | System-wide comparable RevPAR | FY2023 | +10% – +12% | Raised |
| Jul 26, 2023 | Adjusted EBITDA | Q3 FY2023 | $790.00M – $810.00M | New |
| Jul 26, 2023 | Adjusted EBITDA | FY2023 | $2.98B – $3.03B | Raised |
| Jul 26, 2023 | Diluted EPS, adjusted for special items | Q3 FY2023 | $1.60 – $1.65 | New |
| Jul 26, 2023 | Diluted EPS, adjusted for special items | FY2023 | $5.93 – $6.06 | Raised |
| Jul 26, 2023 | Diluted EPS | Q3 FY2023 | $1.49 – $1.54 | New |
| Jul 26, 2023 | Diluted EPS | FY2023 | $5.18 – $5.31 | Raised |
| Jul 26, 2023 | Net income | Q3 FY2023 | $395.00M – $409.00M | New |
| Jul 26, 2023 | Net unit growth | FY2023 | +5% | Lowered |
| Jul 26, 2023 | Capital return | FY2023 | $2.40B – $2.60B | Raised |
| Jul 26, 2023 | General and administrative expenses | FY2023 | $390.00M – $410.00M | Lowered |
| Jul 26, 2023 | Net income | FY2023 | $1.39B – $1.42B | Raised |
| Apr 26, 2023 | Contract acquisition costs and capital expenditures, excluding amounts reimbursed by third parties | FY2023 | $300.00M | New |
| Apr 26, 2023 | System-wide comparable RevPAR, on a currency neutral basis | Q2 FY2023 | +10% – +12% | New |
| Apr 26, 2023 | System-wide comparable RevPAR, on a currency neutral basis | FY2023 | +8% – +11% | New |
| Apr 26, 2023 | Adjusted EBITDA | Q2 FY2023 | $770.00M – $790.00M | New |
| Apr 26, 2023 | Adjusted EBITDA | FY2023 | $2.88B – $2.95B | Raised |
| Apr 26, 2023 | Diluted EPS, adjusted for special items | Q2 FY2023 | $1.54 – $1.59 | New |
| Apr 26, 2023 | Diluted EPS, adjusted for special items | FY2023 | $5.68 – $5.88 | Raised |
| Apr 26, 2023 | Diluted EPS | Q2 FY2023 | $1.45 – $1.50 | New |
| Apr 26, 2023 | Diluted EPS | FY2023 | $4.95 – $5.14 | Lowered |
| Apr 26, 2023 | Net income | Q2 FY2023 | $387.00M – $401.00M | New |
| Apr 26, 2023 | Net unit growth | FY2023 | +5% – +5.5% | Reaffirmed |
| Apr 26, 2023 | Capital return | FY2023 | $1.80B – $2.20B | Raised |
| Apr 26, 2023 | General and administrative expenses | FY2023 | $390.00M – $410.00M | Lowered |
| Apr 26, 2023 | Net income | FY2023 | $1.33B – $1.39B | Raised |
| Feb 9, 2023 | Contract acquisition costs and capital expenditures, excluding amounts indirectly reimbursed by third parties | FY2023 | $300.00M | New |
| Feb 9, 2023 | System-wide comparable RevPAR | Q1 FY2023 | +23% – +27% | New |
| Feb 9, 2023 | System-wide comparable RevPAR | FY2023 | +4% – +8% | New |
| Feb 9, 2023 | Adjusted EBITDA | Q1 FY2023 | $590.00M – $610.00M | New |
| Feb 9, 2023 | Adjusted EBITDA | FY2023 | $2.80B – $2.90B | New |
| Feb 9, 2023 | Diluted EPS, adjusted for special items | Q1 FY2023 | $1.08 – $1.14 | New |
| Feb 9, 2023 | Diluted EPS, adjusted for special items | FY2023 | $5.42 – $5.68 | New |
| Feb 9, 2023 | Diluted EPS | Q1 FY2023 | $1.00 – $1.06 | New |
| Feb 9, 2023 | Diluted EPS | FY2023 | $5.10 – $5.36 | New |
| Feb 9, 2023 | Net income | Q1 FY2023 | $271.00M – $287.00M | New |
| Feb 9, 2023 | Net unit growth | FY2023 | +5% – +5.5% | New |
| Feb 9, 2023 | Capital return | FY2023 | $1.70B – $2.10B | New |
| Feb 9, 2023 | Net income | FY2023 | $1.38B – $1.45B | New |
| Feb 9, 2023 | General and administrative expenses | FY2023 | $390.00M – $410.00M | Lowered |
| Oct 26, 2022 | Contract acquisition costs and capital expenditures, excluding amounts indirectly reimbursed by hotel owners | FY2022 | $250.00M – $275.00M | Reaffirmed |
| Oct 26, 2022 | System-wide comparable RevPAR, on a currency neutral basis | Q4 FY2022 | +19% – +23% | New |
| Oct 26, 2022 | System-wide comparable RevPAR, on a currency neutral basis | FY2022 | +40% – +43% | Raised |
| Oct 26, 2022 | Adjusted EBITDA | Q4 FY2022 | $641.00M – $671.00M | New |
| Oct 26, 2022 | Adjusted EBITDA | FY2022 | $2.50B – $2.53B | Raised |
| Oct 26, 2022 | Diluted EPS, adjusted for special items | Q4 FY2022 | $1.15 – $1.23 | New |
| Oct 26, 2022 | Diluted EPS, adjusted for special items | FY2022 | $4.46 – $4.54 | Raised |
| Oct 26, 2022 | Diluted EPS | Q4 FY2022 | $1.08 – $1.15 | New |
| Oct 26, 2022 | Diluted EPS | FY2022 | $4.40 – $4.48 | Raised |
| Oct 26, 2022 | Net income | Q4 FY2022 | $295.00M – $316.00M | New |
| Oct 26, 2022 | Net unit growth | FY2022 | +5% | Reaffirmed |
| Oct 26, 2022 | Capital return | FY2022 | $1.50B – $1.90B | Reaffirmed |
| Oct 26, 2022 | General and administrative expenses | FY2022 | $380.00M – $400.00M | Lowered |
| Oct 26, 2022 | Net income | FY2022 | $1.22B – $1.24B | Raised |
| Jul 27, 2022 | Contract acquisition costs and capital expenditures, excluding amounts indirectly reimbursed by hotel owners | FY2022 | $250.00M – $275.00M | New |
| Jul 27, 2022 | System-wide comparable RevPAR | Q3 FY2022 | +25% – +30% | New |
| Jul 27, 2022 | System-wide comparable RevPAR | FY2022 | +37% – +43% | Raised |
| Jul 27, 2022 | Adjusted EBITDA | Q3 FY2022 | $660.00M – $690.00M | New |
| Jul 27, 2022 | Adjusted EBITDA | FY2022 | $2.40B – $2.50B | Raised |
| Jul 27, 2022 | Diluted EPS, adjusted for special items | Q3 FY2022 | $1.16 – $1.24 | New |
| Jul 27, 2022 | Diluted EPS, adjusted for special items | FY2022 | $4.21 – $4.46 | Raised |
| Jul 27, 2022 | Diluted EPS | Q3 FY2022 | $1.09 – $1.16 | New |
| Jul 27, 2022 | Diluted EPS | FY2022 | $4.11 – $4.36 | Raised |
| Jul 27, 2022 | Net income | Q3 FY2022 | $303.00M – $324.00M | New |
| Jul 27, 2022 | Net unit growth | FY2022 | +5% | Reaffirmed |
| Jul 27, 2022 | Capital return | FY2022 | $1.50B – $1.90B | Raised |
| Jul 27, 2022 | Net income | FY2022 | $1.15B – $1.22B | Raised |
| Jul 27, 2022 | General and administrative expenses | FY2022 | $400.00M – $420.00M | Lowered |
| May 3, 2022 | Contract acquisition costs and capital expenditures, excluding amounts indirectly reimbursed by hotel owners | FY2022 | $250.00M – $275.00M | New |
| May 3, 2022 | System-wide comparable RevPAR | Q2 FY2022 | +45% – +50% | New |
| May 3, 2022 | System-wide comparable RevPAR | FY2022 | +32% – +38% | New |
| May 3, 2022 | Adjusted EBITDA | Q2 FY2022 | $590.00M – $610.00M | New |
| May 3, 2022 | Adjusted EBITDA | FY2022 | $2.25B – $2.35B | New |
| May 3, 2022 | Diluted EPS, adjusted for special items | Q2 FY2022 | $0.98 – $1.03 | New |
| May 3, 2022 | Diluted EPS, adjusted for special items | FY2022 | $3.77 – $4.02 | New |
| May 3, 2022 | Diluted EPS, before special items | Q2 FY2022 | $0.89 – $0.94 | New |
| May 3, 2022 | Diluted EPS, before special items | FY2022 | $3.56 – $3.81 | New |
| May 3, 2022 | Net income | Q2 FY2022 | $250.00M – $264.00M | New |
| May 3, 2022 | Net unit growth | FY2022 | +5% | Reaffirmed |
| May 3, 2022 | Capital return | FY2022 | $1.40B – $1.80B | New |
| May 3, 2022 | General and administrative expenses | FY2022 | $410.00M – $430.00M | Lowered |
| May 3, 2022 | Net income | FY2022 | $1.00B – $1.07B | New |
| Feb 16, 2022 | net unit growth | FY2022 | +5% | New |
| Oct 27, 2021 | net unit growth | FY2021 | +5% – +5.5% | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases Hilton Worldwide filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Update
- Results
- News
- News
- Results
- Results
- News
- News
- Results
- Results
- News
- News
- Results
- Results